Next, to further prove the correlation between DEGs and tumour immunology, GSEA was used to show that TP53wt patients with LUAD were enriched in 324 biological processes, including 2 immune‐related functional pathways: GO_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE and GO_INNATE_IMMUNE_ RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY (Figure 1C), which further confirmed the potential correlation between immunology and TP53 status. The gene discussed is TP53; the disease is neoplasm.